Chinese Diabetes Cure Claims Ignored by Pharma Industry

Chinese Researchers and Type 2 Diabetes: The Business That Won't Cure You

A headline circulating in economic forums claims Chinese scientists have cured type 2 diabetes, causing tremors in the pharmaceutical industry. The news, spread via digital media links, has triggered a storm of skepticism and unresolved questions. Behind the announcement lies an uncomfortable query: with billions at stake and millions of chronic patients, why is there still no cure available through public healthcare?

What the Announcement Says and Why No One Believes It

The discovery is presented as cell therapy capable of regenerating insulin-producing pancreatic cells. On paper, it sounds revolutionary. In practice, thread readers dismantle it with a textbook argument: type 2 diabetes is not just about lack of insulin, but insulin resistance. This resistance isn't fixed by transplanting new cells because the body still fails to respond to the hormone. "If you don't fix that, it doesn't matter what you transplant," summarizes a comment that has become the axis of skepticism.

Some go further, labeling the announcement journalistic clickbait: the therapy is so early-stage that calling it a cure is, at best, premature. The underlying problem—resistance—would remain intact.

The Business Is in Chronic Treatment, Not the Cure

Economic suspicion runs throughout the debate. What brings more money: a drug that cures or one taken daily for decades? For many participants, the answer is obvious and explains why a cure isn't researched: the business is in the chronic patient.

The US opioid industry case is mentioned, which turned millions into addicts and led to a fentanyl crisis with over 100,000 overdose deaths per year. Also noted are seven million Spaniards with chronic kidney problems, a 28% increase in ten years, as a symptom of something deeper. The repeated conclusion: curing isn't profitable.

Can Diet Reverse Type 2 Diabetes?

Here consensus breaks down. One faction argues type 2 diabetes reverses with ketogenic diet and intermittent fasting: without carbs, the body enters ketosis, burns fat, and stabilizes blood glucose. Some claim they left years of discomfort behind by trinc this path.

Objections arrive quickly: ketosis halts deterioration, it doesn't cure. Insulin resistance persists, and one pizza returns you to square one. Others point out prolonged fasting raises cortisol, blocking insulin action, though it also reduces basal insulin. The nuance matters: controlling is not the same as curing.

Public Healthcare Diagnoses, Doesn't Research

One argument strongly threads through the discussion: healthcare, public or private, doesn't research; it diagnoses and treats. Research goes through another channel, where expected return rules. Hence the question if any chronic disease has been cured by public healthcare. The given answer is uncomfortable: few, and those took decades.

Meanwhile, type 2 diabetes spreads. China is cited, with over 10% of its population having type 2 diabetes, and countries like Mexico or the Philippines, where carb intake and industrial pastry rise have spiked cases. Prediabetes affects a huge number of people who don't know it.

---

The Chinese announcement remains, for now, just that: an announcement. Insulin resistance stays there, the chronic treatment business too, and the fundamental question—why isn't what could be cured being cured—remains unanswered. As one participant says: "99% of diabetics prefer remaining diabetic than changing their diet." Maybe the problem isn't just Big Pharma.